MAIA Biotechnology Inc (MAIA)
MAIA Biotechnology Market Cap: 72.28M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 72.28M |
May 16, 2024 | 68.13M |
May 15, 2024 | 62.67M |
May 14, 2024 | 62.02M |
May 13, 2024 | 62.77M |
May 10, 2024 | 63.39M |
May 09, 2024 | 59.48M |
May 08, 2024 | 62.57M |
May 07, 2024 | 69.15M |
May 06, 2024 | 68.12M |
May 03, 2024 | 67.51M |
May 02, 2024 | 64.83M |
May 01, 2024 | 60.10M |
April 30, 2024 | 60.30M |
April 29, 2024 | 66.07M |
April 26, 2024 | 60.51M |
April 25, 2024 | 55.16M |
April 24, 2024 | 55.36M |
April 23, 2024 | 50.63M |
April 22, 2024 | 46.51M |
April 19, 2024 | 44.25M |
April 18, 2024 | 40.34M |
April 17, 2024 | 40.75M |
April 16, 2024 | 42.40M |
April 15, 2024 | 41.99M |
Date | Value |
---|---|
April 12, 2024 | 45.38M |
April 11, 2024 | 50.01M |
April 10, 2024 | 50.63M |
April 09, 2024 | 52.89M |
April 08, 2024 | 51.25M |
April 05, 2024 | 48.37M |
April 04, 2024 | 45.28M |
April 03, 2024 | 47.75M |
April 02, 2024 | 48.37M |
April 01, 2024 | 51.04M |
March 28, 2024 | 45.28M |
March 27, 2024 | 49.61M |
March 26, 2024 | 48.81M |
March 25, 2024 | 51.01M |
March 22, 2024 | 42.21M |
March 21, 2024 | 38.81M |
March 20, 2024 | 32.15M |
March 19, 2024 | 32.93M |
March 18, 2024 | 29.22M |
March 15, 2024 | 27.08M |
March 14, 2024 | 25.52M |
March 13, 2024 | 22.76M |
March 12, 2024 | 22.25M |
March 11, 2024 | 22.05M |
March 08, 2024 | 22.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Cyclacel Pharmaceuticals Inc | 3.019M |
Avid Bioservices Inc | 578.94M |
Oragenics Inc | 10.44M |
NeuBase Therapeutics Inc | 1.410M |
Viking Therapeutics Inc | 7.388B |
Market Cap Related Metrics
Price | 3.28 |
Earnings Yield | -47.73% |